SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001753926-24-000443
Filing Date
2024-03-01
Accepted
2024-03-01 17:10:44
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G g084087_13g.htm SC 13G 39029
  Complete submission text file 0001753926-24-000443.txt   40584
Mailing Address 685 US HIGHWAY ONE NORTH BRUNSWICK NJ 08902
Business Address 685 US HIGHWAY ONE NORTH BRUNSWICK NJ 08902 9176446313
Chromocell Therapeutics Corp (Subject) CIK: 0001919246 (see all company filings)

IRS No.: 863335449 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-94460 | Film No.: 24711486
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 25 AND 28 NORTH WALL QUAY DUBLIN L2 D01 H104
Business Address 25 AND 28 NORTH WALL QUAY DUBLIN L2 D01 H104 (203) 400-8579
Motif Pharmaceuticals Ltd. (Filed by) CIK: 0001988875 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: SC 13G